Table 1.

Characteristics of patients who had cardiac arrest (CA) with and without concomitant COVID-19 infection.

Characteristics	CA with concomitant COVID-19 infection N = 31,170 (11.92%)	CA without concomitant COVID-19 infection N = 230,260 (88.08%)	P value
Age (Median)	67	65	<0.001
Female	39.40	42.17	<0.001
Race			<0.001
White	41.00	61.35
Black	23.88	20.24
Hispanic	25.30	11.06
Coronary artery disease	24.45	32.60	<0.001
Prior myocardial infarction	4.76	6.88	<0.001
Hypertension	75.38	68.38	<0.001
Peripheral artery disease	5.05	8.82	<0.001
Diabetes mellitus	53.74	38.50	<0.001
Hyperlipidemia	41.74	36.65	<0.001
Congestive heart failure	29.48	42.89	<0.001
COPD	22.43	26.19	<0.001
Valvular disease	5.76	10.86	<0.001
End stage renal disease	10.14	10.48	0.064
STEMI	1.96	6.37	<0.001
NSTEMI	5.73	9.47	<0.001
Sepsis	38.48	28.38	<0.001
Pulmonary Embolism	5.10	3.27	<0.001
Ventricular tachycardia	9.46	13.75	<0.001
Ventricular fibrillation	6.29	12.77	<0.001
Left heart catheterization	1.36	12.21	<0.001
Percutaneous coronary intervention	0.67	6.27	<0.001
Coronary artery bypass surgery	0.03	1.37	<0.001
Acute kidney injury	63.46	51.82	<0.001
ESRD on dialysis	0.13	0.04	<0.001
Respiratory failure	72.62	66.68	<0.001
RF requiring mechanical Ventilation	53.29	51.98	<0.001
Cardiogenic Shock	2.82	6.92	<0.001

Abbreviations: CA- cardiac arrest; COPD- chronic obstructive pulmonary disease; STEMI- ST-segment elevation myocardial infarction; NSTEMI- non-ST-segment elevation myocardial infarction; ESRD- end stage renal disease; RF- respiratory failure.